General Information
Version
1.3, 03/17/2022
Revision date
2022-03-17
Product name
YERVOY (ipilimumab) Injection, for intravenous infusion
Product Synonyms
MDX-010; Ipilimumab Drug Substance; Ipilimumab Concentrate for Solution for
CAS No.
477202-00-9
1.2.1 Relevant identified uses
This material is a finished drug product for patient use. It is used in the treatment of cancer. It is a protein
Emergency telephone
+(61)-290372994
Icons in SDS
Company Information
company name
Bristol-Myers Squibb Australia Pty Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
MG-GBS-MSDS-Request@bms.com
Section 2
SECTION 2: Hazards identification
UN Globally Harmonized System (GHS)
2.1 Classification of the substance or mixture
Not Rated Substance not fully tested. Avoid ingestion, inhalation, and eye contact.
Precautionary statements
Wash hands after handling to minimize exposure. Handle as a potentially hazardous material.
Further information
May enhance the potential for hypersensitivity and dermal sensitization response to other compounds. This effect is due to the mechanism of action. 0.3% of the mixture consists of ingredient(s) of unknown acute toxicity. 1.8% of the mixture consists of ingredients(s) of unknown hazards to the aquatic environment.